BOROSCI
BOROSCI · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for BOROSCI quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
No announcements available from NSE right now.
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
No corporate actions available from NSE right now.
Board Meetings
20 May 2026
To consider and approve the financial results for the quarter & financial year ended March 31, 2026 and Fund Raising
20 May 2026
BOROSIL SCIENTIFIC LIMITED has informed the Exchange about Board Meeting to be held on 20-May-2026 to consider and approve the Quarterly Audited Financial results of the Company for the period ended March 2026 and Fund raising.
11 Feb 2026
To consider and approve the financial results for the period ended December 31, 2025
11 Feb 2026
BOROSIL SCIENTIFIC LIMITED has informed the Exchange about Board Meeting to be held on 11-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
06 Nov 2025
BOROSIL SCIENTIFIC LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 .
06 Nov 2025
To consider and approve the financial results for the period ended September 30, 2025
11 Aug 2025
BOROSIL SCIENTIFIC LIMITED has informed the Exchange about Board Meeting to be held on 11-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 .
11 Aug 2025
To consider and approve the financial results for the period ended Jun 30, 2025